ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes.

Fei-Yuan Yu Qian Xu Qi-Yao Wei Hai-Ying Mo Qiu-Hua Zhong Xiao-Yun Zhao Andy T Y Lau Yan-Ming Xu

Published in: Journal of cancer research and clinical oncology (2022)

Our results suggest that ACC2 is a potential diagnostic and prognostic marker that negatively correlated with clinical outcomes in lung adenocarcinoma.

Keyphrases